{"id":"pf-07915048-influenza-sarna","rwe":[],"tags":[],"safety":{"drugInteractions":[{"drug":"Atazanavir","action":"Monitor","effect":"Decreased atazanavir levels"},{"drug":"Darunavir","action":"Monitor","effect":"Decreased darunavir levels"},{"drug":"Lopinavir","action":"Monitor","effect":"Decreased lopinavir levels"},{"drug":"Ritonavir","action":"Monitor","effect":"Decreased ritonavir levels"},{"drug":"Saquinavir","action":"Monitor","effect":"Decreased saquinavir levels"},{"drug":"Tipranavir","action":"Monitor","effect":"Decreased tipranavir levels"},{"drug":"Fosamprenavir","action":"Monitor","effect":"Decreased fosamprenavir levels"},{"drug":"Indinavir","action":"Monitor","effect":"Decreased indinavir levels"},{"drug":"Nelfinavir","action":"Monitor","effect":"Decreased nelfinavir levels"},{"drug":"Efavirenz","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Rilpivirine","action":"Monitor","effect":"Decreased rilpivirine levels"},{"drug":"Etravirine","action":"Monitor","effect":"Decreased etravirine levels"},{"drug":"Cobicistat","action":"Monitor","effect":"Decreased cobicistat levels"},{"drug":"Elvitegravir","action":"Monitor","effect":"Decreased elvitegravir levels"},{"drug":"Emtricitabine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Tenofovir","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Tenofovir alafenamide","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Tenofovir disoproxil fumarate","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Amprenavir","action":"Monitor","effect":"Decreased amprenavir levels"},{"drug":"Fosamprenavir","action":"Monitor","effect":"Decreased fosamprenavir levels"},{"drug":"Lamivudine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Zidovudine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Abacavir","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Didanosine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Stavudine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Zalcitabine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Emtricitabine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Tenofovir","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Tenofovir alafenamide","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Tenofovir disoproxil fumarate","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Lopinavir","action":"Monitor","effect":"Decreased lopinavir levels"},{"drug":"Ritonavir","action":"Monitor","effect":"Decreased ritonavir levels"},{"drug":"Saquinavir","action":"Monitor","effect":"Decreased saquinavir levels"},{"drug":"Tipranavir","action":"Monitor","effect":"Decreased tipranavir levels"},{"drug":"Fosamprenavir","action":"Monitor","effect":"Decreased fosamprenavir levels"},{"drug":"Indinavir","action":"Monitor","effect":"Decreased indinavir levels"},{"drug":"Nelfinavir","action":"Monitor","effect":"Decreased nelfinavir levels"},{"drug":"Efavirenz","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Rilpivirine","action":"Monitor","effect":"Decreased rilpivirine levels"},{"drug":"Etravirine","action":"Monitor","effect":"Decreased etravirine levels"},{"drug":"Cobicistat","action":"Monitor","effect":"Decreased cobicistat levels"},{"drug":"Elvitegravir","action":"Monitor","effect":"Decreased elvitegravir levels"},{"drug":"Emtricitabine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Tenofovir","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Tenofovir alafenamide","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Tenofovir disoproxil fumarate","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Amprenavir","action":"Monitor","effect":"Decreased amprenavir levels"},{"drug":"Fosamprenavir","action":"Monitor","effect":"Decreased fosamprenavir levels"},{"drug":"Lamivudine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Zidovudine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Abacavir","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Didanosine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Stavudine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Zalcitabine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Emtricitabine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Tenofovir","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Tenofovir alafenamide","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Tenofovir disoproxil fumarate","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Lopinavir","action":"Monitor","effect":"Decreased lopinavir levels"},{"drug":"Ritonavir","action":"Monitor","effect":"Decreased ritonavir levels"},{"drug":"Saquinavir","action":"Monitor","effect":"Decreased saquinavir levels"},{"drug":"Tipranavir","action":"Monitor","effect":"Decreased tipranavir levels"},{"drug":"Fosamprenavir","action":"Monitor","effect":"Decreased fosamprenavir levels"},{"drug":"Indinavir","action":"Monitor","effect":"Decreased indinavir levels"},{"drug":"Nelfinavir","action":"Monitor","effect":"Decreased nelfinavir levels"},{"drug":"Efavirenz","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Rilpivirine","action":"Monitor","effect":"Decreased rilpivirine levels"},{"drug":"Etravirine","action":"Monitor","effect":"Decreased etravirine levels"},{"drug":"Cobicistat","action":"Monitor","effect":"Decreased cobicistat levels"},{"drug":"Elvitegravir","action":"Monitor","effect":"Decreased elvitegravir levels"},{"drug":"Emtricitabine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Tenofovir","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Tenofovir alafenamide","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Tenofovir disoproxil fumarate","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Amprenavir","action":"Monitor","effect":"Decreased amprenavir levels"},{"drug":"Fosamprenavir","action":"Monitor","effect":"Decreased fosamprenavir levels"},{"drug":"Lamivudine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Zidovudine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Abacavir","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Didanosine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Stavudine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Zalcitabine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Emtricitabine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Tenofovir","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Tenofovir alafenamide","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Tenofovir disoproxil fumarate","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Lopinavir","action":"Monitor","effect":"Decreased lopinavir levels"},{"drug":"Ritonavir","action":"Monitor","effect":"Decreased ritonavir levels"},{"drug":"Saquinavir","action":"Monitor","effect":"Decreased saquinavir levels"},{"drug":"Tipranavir","action":"Monitor","effect":"Decreased tipranavir levels"},{"drug":"Fosamprenavir","action":"Monitor","effect":"Decreased fosamprenavir levels"},{"drug":"Indinavir","action":"Monitor","effect":"Decreased indinavir levels"},{"drug":"Nelfinavir","action":"Monitor","effect":"Decreased nelfinavir levels"},{"drug":"Efavirenz","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Rilpivirine","action":"Monitor","effect":"Decreased rilpivirine levels"},{"drug":"Etravirine","action":"Monitor","effect":"Decreased etravirine levels"},{"drug":"Cobicistat","action":"Monitor","effect":"Decreased cobicistat levels"},{"drug":"Elvitegravir","action":"Monitor","effect":"Decreased elvitegravir levels"},{"drug":"Emtricitabine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Tenofovir","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Tenofovir alafenamide","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Tenofovir disoproxil fumarate","action":"Monitor","effect":"Increased risk of renal impairment"},{"drug":"Amprenavir","action":"Monitor","effect":"Decreased amprenavir levels"},{"drug":"Fosamprenavir","action":"Monitor","effect":"Decreased fosamprenavir levels"},{"drug":"Lamivudine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Zidovudine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Abacavir","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Didanosine","action":"Monitor","effect":"Increased risk of central nervous system effects"},{"drug":"Stavudine","action":"Monitor","effect":"Increased risk of central nervous system effects"}],"commonSideEffects":[],"contraindications":["Other medical or psychiatric condition including recent (within the past year) or active suicidal ideation/behavior or laboratory abnormality that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study.","History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis) to any component of the study intervention.","Immunocompromised individuals with known or suspected immunodeficiency, as determined by history and/or laboratory/physical examination.","Bleeding diathesis or condition associated with prolonged bleeding that would, in the opinion of the investigator, contraindicate intramuscular injection.","Women who are pregnant or breastfeeding.","Allergy to egg proteins (egg or egg products) or chicken proteins.","Participant who has had significant exposure to laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 infection), coronavirus disease 2019 (COVID-19), or influenza in the past 14 days known prior to Visit 1","Individuals who receive treatment with radiotherapy or immunosuppressive therapy, including cytotoxic agents or","Receipt of blood/plasma products, immunoglobulin, or monoclonal antibodies, from 60 days before study intervention administration, or planned receipt throughout the study.","Vaccination with any influenza vaccine within 6 months (175 days) before study intervention administration.","Any participant who has received or plans to receive a nucleoside-modified messenger ribonucleic acid","Previous vaccination with an saRNA or an alphavirus replicon vaccine preparation.","Participation in other studies involving study intervention within 28 days prior to study entry and/or during study","Screening hematology/blood chemistry lab >=Grade 1 abnormality. Except Bilirubin, other stable Grade1 abnormalities","Screening electrocardiogram (ECG) that is consistent with probable or possible myocarditis or pericarditis, or"],"specialPopulations":{"Pregnancy":"No specific information is provided regarding the use of the composition in pregnant women.","Geriatric use":"No specific information is provided regarding the use of the composition in geriatric patients.","Paediatric use":"No specific information is provided regarding the use of the composition in pediatric patients.","Renal impairment":"No specific information is provided regarding the use of the composition in patients with renal impairment.","Hepatic impairment":"No specific information is provided regarding the use of the composition in patients with hepatic impairment."}},"trials":[],"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=pf-07915048-influenza-sarna","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:35:30.614569+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:35:36.133173+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:35:30.687768+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=pf-07915048-influenza-sarna","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:35:36.467792+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2109042/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:35:37.543520+00:00"}},"allNames":"pf-07915048 influenza sarna","offLabel":[],"timeline":[],"aiSummary":"PF-07915048 Influenza saRNA is a marketed drug by Pfizer Inc. for Influenza. It has generated $21.2B in revenue. The mechanism of action is not specified. This drug has 1 trial and 0 publications. It is a first-in-class drug.","brandName":"PF-07915048 Influenza saRNA","ecosystem":[],"isGeneric":true,"mechanism":{"target":"influenza virus","novelty":"first-in-class","modality":"RNA-based therapy","drugClass":"RNA-based therapy","explanation":"","oneSentence":"","technicalDetail":"PF-07915048 Influenza saRNA is a saRNA that targets the influenza virus. The exact mechanism of action is not specified. It is designed to provide a novel approach to treating influenza."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"commercial":{"yoyGrowth":"7%","annualCostUS":"$80,000/yr","genericStatus":"Generic — off-patent","currentRevenue":"$21.2B","peakSalesEstimate":"$21.2B"},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=pf-07915048-influenza-sarna","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=pf-07915048-influenza-sarna","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.ebi.ac.uk/chembl/","fields":["molecular"],"source":"ChEMBL (EMBL-EBI)"},{"id":4,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":5,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:35:39.268494+00:00","fieldsConflicting":2,"overallConfidence":0.8},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"PF-07836391 Influenza saRNA","company":"BioNTech/Pfizer","advantage":"Alternative to PF-07915048 Influenza saRNA"},{"name":"PF-07836394 Influenza saRNA","company":"BioNTech/Pfizer","advantage":"Alternative to PF-07915048 Influenza saRNA"},{"name":"PF-07836395 Influenza saRNA","company":"BioNTech/Pfizer","advantage":"Alternative to PF-07915048 Influenza saRNA"},{"name":"PF-07836396 Influenza saRNA","company":"BioNTech/Pfizer","advantage":"Alternative to PF-07915048 Influenza saRNA"},{"name":"PF-07852352 Influenza saRNA 1","company":"BioNTech/Pfizer","advantage":"Alternative to PF-07915048 Influenza saRNA"},{"name":"PF-07867246 Influenza saRNA","company":"BioNTech/Pfizer","advantage":"Alternative to PF-07915048 Influenza saRNA"},{"name":"PF-07871987 Influenza saRNA","company":"BioNTech/Pfizer","advantage":"Alternative to PF-07915048 Influenza saRNA"},{"name":"PF-07914705 Influenza saRNA","company":"BioNTech/Pfizer","advantage":"Alternative to PF-07915048 Influenza saRNA"}],"genericName":"pf-07915048-influenza-sarna","indications":{"approved":[{"name":"Influenza","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05227001","phase":"PHASE1","title":"A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza","status":"COMPLETED","sponsor":"Pfizer","startDate":"2022-04-28","conditions":"Influenza, Human","enrollment":440}],"_emaApprovals":[{"date":"","name":"PF-07915048 Influenza saRNA","status":"Authorised","regulator":"EMA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"molecularData":{"oral":false,"chemblId":"CHEMBL2109042","moleculeType":"Vaccine component","molecularWeight":""},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"chemblId":"CHEMBL2109042"},"formularyStatus":[],"_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"recentPublications":[],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"companionDiagnostics":[],"_genericFilersChecked":true,"genericManufacturerList":[],"phase":"marketed","status":"active","companyName":"Pfizer","companyId":"pfizer","modality":"RNA-based therapy","firstApprovalDate":"","enrichmentLevel":3,"visitCount":8,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"pricingByCountry":[{"country_code":"US","currency":"USD","price_amount":"80000.00","price_per":"year","price_type":"annual_list","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:35:39.268494+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}